LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability

PLoS ONE

Volumn 2, Issue 5, 2007, Pages

  Estécio, Marcos R H ^a   Gharibyan, Vazganush ^a   Shen, Lanlan ^a   Ibrahim, Ashraf E K ^b   Doshi, Ketan ^c   He, Rong ^a   Jelinek, Jaroslav ^a   Yang, Allen S ^d   Yan, Pearlly S ^e   Huang, Tim H M ^e   Tajara, Eloiza H ^f   Issa, Jean Pierre J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; REPETITIVE DNA; MICROSATELLITE DNA; PRIMER DNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; COLORECTAL CARCINOMA; CPG ISLAND; DEMETHYLATION; DNA HYPERMETHYLATION; DNA HYPOMETHYLATION; DNA METHYLATION; FEMALE; GENE CLUSTER; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MICROSATELLITE INSTABILITY; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; TISSUE SPECIFICITY; GENETICS; LONG INTERSPERSED REPEAT; NEOPLASM;

BASE SEQUENCE; DNA METHYLATION; DNA PRIMERS; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MICROSATELLITE REPEATS; NEOPLASMS;

EID: 36849059066     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000399     Document Type: Article

References (30)

1. Walker MS,Becker FF (1981) DNA methylase activity of normal liver, regenerating liver, and a transplantable hepatocellular carcinoma. Cancer Biochem Biophys 1981; 5: 169-173.
2. Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92.
3. Gama-Sosa MA, Slagel VA, Trewyn RW, Oxenhandler R, Kuo KC, et al. (1983) The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res 11: 6883-6894.
4. Lu LJ, Randerath E, Randerath K (1983) DNA hypomethylation in Morris hepatomas. Cancer Lett 19: 231-239.
5. Baylin SB, Hoppener JW, de Bustros A, Steenbergh PH, Lips CJ, et al. (1986) DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res 46: 2917-2922.
6. Baylin SB, Fearon ER, Vogelstein B, de Bustros A, Sharkis SJ, et al. (1987) Hypermethylation of the 5′ region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood 70: 412-417.
7. Jones PA, Wolkowicz MJ, Rideout WM 3rd, Gonzales FA, Marziasz CM, et al. (1990) De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 87: 6117-6121.
8. Sugimura T, Ushijima T (2000) Genetic and epigenetic alterations in carcinogenesis. Mutat Res 462: 235-246.
9. Toyota M, Issa JP (2005) Epigenetic changes in solid and hematopoietic tumors. Semin Oncol 32: 521-530.
10. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, et al. (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7: 536-540.
11. Suzuki K, Suzuki I, Leodolter A, Alonso S, Horiuchi S, et al. (2006) Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell 9: 199-207.
12. Gonzalgo ML, Liang G, Spruck CH 3rd, Zingg JM, Rideout WM 3rd, et al. (1997) Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res 57: 594-599.
13. Smiraglia DJ, Plass C (2000) The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene 21: 5414-5426.
14. Piotrowski A, Benetkiewicz M, Menzel U, de Stahl TD, Mantripragada K, et al. (2006) Microarray-based survey of CpG islands identifies concurrent hyper-and hypomethylation patterns in tissues derived from patients with breast cancer. Genes Chromosomes Cancer 45: 656-667.
15. Matsuzaki K, Deng G, Tanaka H, Kakar S, Miura S, et al. (2003) The relationship between global methylation level, loss of heterozygosity, and microsatellite instability in sporadic colorectal cancer. Clin Cancer Res 11: 8564-8569.
16. Deng G, Nguyen A, Tanaka H, Matsuzaki K, Bell I, et al. (2006) Regional hypermethylation and global hypomethylation are associated with altered chromatin conformation and histone acetylation in colorectal cancer. Int J Cancer 118: 2999-3005.
17. Frigola J, Sole X, Paz MF, Moreno V, Esteller M, et al. (2005) Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum Mol Genet 14: 319-326.
18. Ehrlich M, Woods CB, Yu MC, Dubeau L, Yang F, et al. (2006) Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors. Oncogene 25: 2636-2645.
19. Toyota M, Ohe-Toyota M, Ahuja N, Issa JP (2000) Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl. Acad. Sci. USA 97: 710-715.
20. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, et al. (1999) Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307-2312.
21. Yang AS, Doshi KD, Choi SW, Mason JB, Mannari RK, et al. (2006) DNA methylation changes after 5-aza-2′-deoxycytidine therapy in patients with leukemia. Cancer Res 66: 5495-5503.
22. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, et al. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 32: e38.
23. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-28.
24. Issa JP (2004) CpG island methylator phenotype in cancer. Nat Rev Cancer 12: 988-993.
25. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96: 8681-8686.
26. Chalitchagorn K, Shuangshoti S, Hourpai N, Kongruttanachok N, Tangkijvanich P, et al. (2004) Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23: 8841-8846.
27. Florl AR, Lower R, Schmitz-Drager BJ, Schulz WA (1999) DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br J Cancer 80: 1312-1321.
28. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, et al. (2003) Induction of tumors in mice by genomic hypomethylation. Science 300: 489-492.
29. Holm TM, Jackson-Grusby L, Brambrink T, Yamada Y, Rideout WM 3rd, et al. (2005) Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8: 275-285.
30. Dennis K, Fan T, Geiman T, Yan Q, Muegge K (2001) Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev 15: 2940-2944.